Kalamazoo, MI, United States of America

Olivier Bezencon

This inventor holds 2 USPTO granted patents. Top assignee: Pharmacia & Upjohn Company. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivier Bezencon. Retrieved from https://idiyas.com/inventor/olivier-bezencon-1ltpz43u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Olivier Bezencon: Innovator in Anti-Viral Compounds

Introduction

Olivier Bezencon is a notable inventor based in Kalamazoo, MI, specializing in the development of innovative pharmaceutical compounds. With two patents to his name, he has made significant contributions to the field of antiviral agents.

Latest Patents

Olivier's latest patent, titled "8-hydroxy-7-substituted quinolines as anti-viral agents," presents novel compounds that hold promise in the fight against viral infections. This invention focuses on 8-hydroxy-7-substituted quinoline compounds, providing a new avenue for therapeutic development in antiviral treatments.

Career Highlights

Olivier Bezencon is currently associated with the Pharmacia & Upjohn Company, a prominent organization in the pharmaceutical industry. His work at this company has facilitated advancements in drug development, particularly in creating effective antiviral solutions.

Collaborations

Throughout his career, Olivier has collaborated with esteemed colleagues such as Valerie Ann Vaillancourt and Joseph Walter Strohbach. These partnerships have played a crucial role in enhancing the research and development process, leading to the successful creation of innovative pharmaceutical compounds.

Conclusion

Olivier Bezencon's inventive contributions exemplify the importance of innovation in the pharmaceutical field. His dedication to developing antiviral agents is a testament to the impact of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…